Novel drug resistance pattern associated with the mutations K70G and M184V in human immunodeficiency virus type 1 reverse transcriptase

被引：10
|
作者：
Bradshaw, D.
Malik, S.
Booth, C.
Van Houtte, M.
Pattery, T.
Waters, A.
Ainsworth, J.
Geretti, A. M.
机构：
[1] Royal Free Hosp, Dept Virol, London NW3 2QG, England
[2] UCL, Sch Med, Royal Free Hosp, London W1N 8AA, England
[3] Virco BVBA, Mechelen, Belgium
[4] N Middlesex Hosp, Dept HIV Med, London, England
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2007年 / 51卷 / 12期
关键词：
D O I：
10.1128/AAC.00687-07
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
We describe an unusual pathway of human immunodeficiency virus type 1 reverse transcriptase resistance during therapy with tenofovir-emtricitabine, characterized initially by the mutations K70E and M184V and later by K70G and M184V, with the two mutations coexisting on the same viral genome. Phenotypic resistance to lamivudine, emtricitabine, abacavir, didanosine, and tenofovir was observed, whereas susceptibility to zidovudine and stavudine was preserved.
引用
收藏
页码：4489 / 4491
页数：3
相关论文
共 50 条
  • [31] ANALYSIS OF MUTATIONS AT POSITION-184 IN REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    BOYER, PL
    HUGHES, SH
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) : 1624 - 1628
  • [32] Major Drug Resistance Mutations on Reverse Transcriptase Gene in Human Immunodeficiency Virus Type-1 in Indonesia: A Systematic Review
    Nurjannah
    Jayanti, Sri
    Tanoerahardjo, Francisca Srioetami
    Al Musyahadah, Ummu Syauqah
    Sukowati, Caecilia Hapsari Ceriapuri
    Massi, Muhammad Nasrum
    CURRENT HIV/AIDS REPORTS, 2024, 21 (02) : 31 - 39
  • [33] INTERACTIONS BETWEEN DRUG-RESISTANCE MUTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    LARDER, BA
    JOURNAL OF GENERAL VIROLOGY, 1994, 75 : 951 - 957
  • [34] Major Drug Resistance Mutations on Reverse Transcriptase Gene in Human Immunodeficiency Virus Type-1 in Indonesia: A Systematic Review
    Sri Nurjannah
    Francisca Srioetami Jayanti
    Ummu Syauqah Tanoerahardjo
    Caecilia Hapsari Ceriapuri Al Musyahadah
    Muhammad Nasrum Sukowati
    Current HIV/AIDS Reports, 2024, 21 : 31 - 39
  • [35] Antiretroviral drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase increase template-switching frequency
    Nikolenko, GN
    Svarovskaia, ES
    Delviks, KA
    Pathak, VK
    JOURNAL OF VIROLOGY, 2004, 78 (16) : 8761 - 8770
  • [36] Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase
    Schuurman, R
    Demeter, L
    Reichelderfer, P
    Tijnagel, J
    de Groot, T
    Boucher, C
    JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (07) : 2291 - 2296
  • [37] Mutations at position 184 of human immunodeficiency virus type-1 reverse transcriptase affect virus titer and viral DNA synthesis
    Julias, JG
    Boyer, PL
    McWilliams, MJ
    Alvord, WG
    Hughes, SH
    VIROLOGY, 2004, 322 (01) : 13 - 21
  • [38] Coresistance to zidovudine and foscarnet is associated with multiple mutations in the human immunodeficiency virus type 1 reverse transcriptase
    Tachedjian, G
    French, M
    Mills, J
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (11) : 3038 - 3043
  • [39] Molecular mechanism by which the K70E mutation in human immunodeficiency virus type 1 reverse transcriptase confers resistance to nucleoside reverse transcriptase inhibitors
    Sluis-Cremer, Nicolas
    Sheen, Chih-Wei
    Zelina, Shannon
    Torres, Pedro S. Argoti
    Parikh, Urvi A.
    Mellors, John W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (01) : 48 - 53
  • [40] The K101P and K103R/V179D mutations in human immunodeficiency virus type 1 reverse transcriptase confer resistance to nonnucleoside reverse transcriptase inhibitors
    Parkin, NT
    Gupta, S
    Chappey, C
    Petropoulos, CJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) : 351 - 354
12345